Expression in Escherichia coli and purification of soluble forms of the F protein of bovine respiratory syncytial virus

Protein Expression and Purification

Volumn 9, Issue 2, 1997, Pages 288-294

  Naval, Jordi ^a   Piñol, Jaume ^a   Rebordosa, Xavier ^a   Serra Hartmann, Xavier ^a   Pérez Pons, Josep A ^a   Querol, Enrique ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; ESCHERICHIA COLI; HUMAN RESPIRATORY SYNCYTIAL VIRUS; ORYCTOLAGUS CUNICULUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0342618453     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0688     Document Type: Article

References (36)

1. Stott E. J., Thomas L. H., Collins A. P., Crouch S., Jebbet J., Smith G. S., Luther P. D., Caswell R. A survey of virus infections of the respiratory tract of cattle and their association with disease. J. Hyg. 85:1980;257-270.
2. K. McIntosh, R. M. Channock, 1985, Respiratory syncytial virus, Virology, 1285, 1304, Raven Press, New York.
3. Lerch R. A., Stott E. J., Wertz G. W. Characterization of bovine respiratory syncytial virus proteins and mRNAs and generation of cDNA clones to the viral mRNAs. J. Virol. 63:1989;833-840.
4. Lerch R. A., Anderson K., Wertz G. W. Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. J. Virol. 64:1990;5559-5569.
5. Walravens K., Kettmann R., Collard A., Coppe P., Burny A. Sequence comparison between the fusion protein of human and bovine respiratory syncytial viruses. J. Gen. Virol. 71:1990;3009-3014.
6. Walsh E. E., Hruska. Monoclonal antibodies to respiratory syncytial virus proteins; identification of the fusion protein. J. Virol. 47:1983;171-177.
7. Walsh E. E., Brandiss M. W., Schlesinger J. J. Purification and characterization of the respiratory syncytial virus fusion protein. J. Gen. Virol. 66:1985;409-415.
8. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 80:1977;54-66.
9. Arumugham R., Hildreth S. W., Paradiso P. R. Evidence that the fusion protein of respiratory syncytial virus exists as a dimer in its native form. Arch. Virol. 106:1989;327-334.
10. Collins P. L., Mottet G. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 72:1991;3095-3101.
11. Wathen M. W., Brideau R. J., Thomsen D. R. Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. J. Infect. Dis. 159:1989;255-264.
12. Wathen M. W., Brideau R. J., Thomsen D. R., Murphy B. R. Characterization of novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. J. Gen. Virol. 70:1989;2625-2635.
13. Trudel M., Stott E. J., Taylor G., Oth D., Mercier G., Nadon F., Séguin C., Simard C., Lacroix M. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection. Arch. Virol. 117:1991;59-71.
14. Homa F. L., Brideau R. J., Lehman D. J., Thomsen D. R., Olmsted R. A., Wathen M. W. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. J. Gen. Virol. 74:1993;1995-1999.
15. Tristram D. A., Welliver R. C., Hogerman D. A., Hildreth S. W., Paradiso P. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine. 12:1994;551-556.
16. Hancock G. E., Speelman D. J., Frenchick P. J., Mineo-Kuhn M. M., Baggs R. B., Hahn D. J. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection. Vaccine. 13:1995;391-400.
17. Murphy B. R., Hall S. L., Kulkarni A. B., Crowe J. E., Collins P. L., Connors M., Karron R. A., Chanock R. M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:1994;13-36.
18. Kimman T. G., Westenbrink F. Immunity to human and bovine respiratory syncytial virus. Arch. Virol. 112:1990;1-25.
19. Anderson L. J., Henry M., Pierik L. T., Tsou C., McIntosh K. Multicenter study of strains of respiratory syncytial virus. J. Inf. Dis. 163:1991;687-692.
20. Martin-Gallardo A., Deich R. A., Fien K. A., Metcalf B. J., Anilionis A., Paradiso P. R. Alcaline phosphatase fusions to the respiratory syncytial virus F protein as an approach to analyze its membrane topology. DNA. 8:1989;659-667.
21. Martin-Gallardo A., Fien K. A., Hu B. T., Farley J. F., Seid R., Collins P. L., Hildreth S. W., Paradiso P. R. Expression of the F glycoprotein gene from human respiratory syncytial virus inEscherichia coli: Virology. 184:1991;428-432.
22. Murby M., Nguyen T. N., Binz H., Uhlén M., Stahl S. Production and recovery of recombinant proteins of low solubility. Pyle D. L. Separations for Biotechnology 3. 1994;336-344 Bookcraft Ltd. Bath.
23. Kennedy H. E., Jones B. V., Tucker E. M., Ford N. J., Clarke S. W., Furze J., Thomas L. H., Stott E. J. Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. J. Gen. Virol. 69:1988;3023-3032.
24. Taylor G., Stott E. J., Furze J., Ford J., Sopp P. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. J. Gen. Virol. 73:1992;2217-2223.
25. Trudel M., Nadon F., Seguin C., Ghoubril S., Payment P., Trepanier P. Immunovirological studies on human respiratory syncytial virus structural proteins. Can. J. Microbiol. 32:1986;15-21.
26. Juncosa M., Pons J., Planas A., Querol E. Improved efficiency in site-directed mutagenesis by PCR using aPyrococcus sp. BioTechniques. 16:1994;820-821.
27. Lerch R. A., Anderson K., Amann V. L., Wertz G. W. Nucleotide sequence analysis of the bovine respiratory syncytial virus fusion protein mRNA and expression from a recombinant vaccinia virus. Virology. 181:1991;118-131.
28. Guan C., Li P., Riggs P. D., Inouye H. Vectors that facilitate the expression and purification of foreign peptides inEscherichia coli. Gene. 67:1987;21-30.
29. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
30. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 103-119.
31. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 490-506.
32. Arbiza J., Taylor G., López J. A., Furze J., Wyld S., Whyte P., Stott J. E., Wertz G., Sullender W., Trudel M., Melero J. A. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73:1992;2225-2234.
33. Trudel M., Nadon F., Séguin C., Dionne G., Lacroix M. Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus. J. Gen. Virol. 68:1987;2273-2280.
34. Sisk W. P., Bradley J. D., Kingsley D., Patterson T. A. Deletion of hydrophobic domains of viral glycoproteins increases the level of their production inEscherichia coli. Gene. 112:1992;157-162.
35. Parsell D. A., Sauer R. T. The structural stability of a protein is an important determinant of its proteolytic susceptibility inEscherichia coli. J. Biol. Chem. 264:1989;7590-7595.
36. Hendrick J. P., Hartl F.-U. Molecular chaperone functions of heat-shock proteins. Annu. Rev. Biochem. 62:1993;349-384.